SRRK 8-K 2026-11-10
Scholar Rock Holding Corp (SRRK) 8-K dated 2026-11-10 — accession 0001193125-26-454423.
Scholar Rock Holding Corp (SRRK) is a biotechnology company listed on US.
SRRK: Scholar Rock Reports Third Quarter 2026 Financial Results and Recent Bu…
This 8-K covers: Material agreement (Item 1.01), Results of operations (Item 2.02), Reg FD disclosure (Item 7.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported SRRK revenue for 2025-12-31 was $0. Net income was -$377.9M. Revenue was down 100.0% from 2022-12-31 to 2025-12-31. SRRK currently screens at market cap $3.42B.
Not investment advice. The SRRK SEC hub lists recent forms. The stock page is the research view.
- Guidance
- guidance from the European Medicines Agency (EMA), Scholar Rock resubmitted the apitegromab Marketing Authorisation Application
Why it matters
- guidance from the European Medicines Agency (EMA), Scholar Rock resubmitted the apitegromab Marketing Authorisation Application